The global Oligonucleotide Synthesis Market, valued at US$8.9 billion in 2024 stood at US$10.5 billion in 2025 and is projected to advance at ...

Tsingke Biotech recently participated in TIDES USA 2025, the leading international event for oligonucleotide and peptide ...

Next-generation technologies will help increase the agility and efficiency of genetic sequencing to tackle several diseases ...

TriLink BioTechnologies®, a division of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), announced a non-exclusive License ...

You may have seen it in the news recently: a baby in Pennsylvania with a rare genetic disorder was healed with a personalized ...

So is it time to add viruses to one's microbiome-feeding regimen of probiotics and prebiotics, synbiotics (which combine the ...

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...

Resolve Therapeutics, a leader in the emerging field of cell-free nucleic acid therapeutics, today announced a collaboration with the Department of Surgery, Duke University School of Medicine to ...

Telesis Bio Inc. (OTCMKTS: TBIO), a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery ...

Explore the explosive growth of Synthetic Oligonucleotides as they revolutionize healthcare, food production, and data storage. Discover how "Oligos" are transforming markets and the untapped ...